172 related articles for article (PubMed ID: 26300002)
1. Intestinal-specific activatable Myb initiates colon tumorigenesis in mice.
Malaterre J; Pereira L; Putoczki T; Millen R; Paquet-Fifield S; Germann M; Liu J; Cheasley D; Sampurno S; Stacker SA; Achen MG; Ward RL; Waring P; Mantamadiotis T; Ernst M; Ramsay RG
Oncogene; 2016 May; 35(19):2475-84. PubMed ID: 26300002
[TBL] [Abstract][Full Text] [Related]
2. Colon epithelial cell differentiation is inhibited by constitutive c-myb expression or mutant APC plus activated RAS.
Ramsay RG; Ciznadija D; Sicurella C; Reyes N; Mitchelhill K; Darcy PK; D'Abaco G; Mantamadiotis T
DNA Cell Biol; 2005 Jan; 24(1):21-9. PubMed ID: 15684716
[TBL] [Abstract][Full Text] [Related]
3. Defective Myb Function Ablates Cyclin E1 Expression and Perturbs Intestinal Carcinogenesis.
Cheasley D; Pereira L; Sampurno S; Sieber O; Jorissen R; Xu H; Germann M; Yuqian Y; Ramsay RG; Malaterre J
Mol Cancer Res; 2015 Aug; 13(8):1185-96. PubMed ID: 25934694
[TBL] [Abstract][Full Text] [Related]
4. Tripartite interactions between Wnt signaling, Notch and Myb for stem/progenitor cell functions during intestinal tumorigenesis.
Germann M; Xu H; Malaterre J; Sampurno S; Huyghe M; Cheasley D; Fre S; Ramsay RG
Stem Cell Res; 2014 Nov; 13(3 Pt A):355-66. PubMed ID: 25290188
[TBL] [Abstract][Full Text] [Related]
5. A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations.
Buchert M; Rohde F; Eissmann M; Tebbutt N; Williams B; Tan CW; Owen A; Hirokawa Y; Gnann A; Orend G; Orner G; Dashwood RH; Heath JK; Ernst M; Janssen KP
Dis Model Mech; 2015 Nov; 8(11):1361-73. PubMed ID: 26398937
[TBL] [Abstract][Full Text] [Related]
6. c-Myb regulates NOX1/p38 to control survival of colorectal carcinoma cells.
Pekarčíková L; Knopfová L; Beneš P; Šmarda J
Cell Signal; 2016 Aug; 28(8):924-36. PubMed ID: 27107996
[TBL] [Abstract][Full Text] [Related]
7. Myb controls intestinal stem cell genes and self-renewal.
Cheasley D; Pereira L; Lightowler S; Vincan E; Malaterre J; Ramsay RG
Stem Cells; 2011 Dec; 29(12):2042-50. PubMed ID: 21997934
[TBL] [Abstract][Full Text] [Related]
8. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
9. Transgenic expression of oncogenic BRAF induces loss of stem cells in the mouse intestine, which is antagonized by β-catenin activity.
Riemer P; Sreekumar A; Reinke S; Rad R; Schäfer R; Sers C; Bläker H; Herrmann BG; Morkel M
Oncogene; 2015 Jun; 34(24):3164-75. PubMed ID: 25109331
[TBL] [Abstract][Full Text] [Related]
10. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
[TBL] [Abstract][Full Text] [Related]
11. RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis.
Hilkens J; Timmer NC; Boer M; Ikink GJ; Schewe M; Sacchetti A; Koppens MAJ; Song JY; Bakker ERM
Gut; 2017 Jun; 66(6):1095-1105. PubMed ID: 27511199
[TBL] [Abstract][Full Text] [Related]
12. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.
Bakker ER; Das AM; Helvensteijn W; Franken PF; Swagemakers S; van der Valk MA; ten Hagen TL; Kuipers EJ; van Veelen W; Smits R
Carcinogenesis; 2013 Nov; 34(11):2629-38. PubMed ID: 23764752
[TBL] [Abstract][Full Text] [Related]
13.
Tabrizian T; Wang D; Guan F; Hu Z; Beck AP; Delahaye F; Huffman DM
Endocr Relat Cancer; 2017 Jun; 24(6):253-265. PubMed ID: 28351943
[TBL] [Abstract][Full Text] [Related]
14. Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression.
Shvab A; Haase G; Ben-Shmuel A; Gavert N; Brabletz T; Dedhar S; Ben-Ze'ev A
Oncogene; 2016 Feb; 35(5):549-57. PubMed ID: 25915847
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the tumor suppressor homeogene Cdx2 by HNF4α in intestinal cancer.
Saandi T; Baraille F; Derbal-Wolfrom L; Cattin AL; Benahmed F; Martin E; Cardot P; Duclos B; Ribeiro A; Freund JN; Duluc I
Oncogene; 2013 Aug; 32(32):3782-8. PubMed ID: 22986531
[TBL] [Abstract][Full Text] [Related]
16. The Myb-p300-CREB axis modulates intestine homeostasis, radiosensitivity and tumorigenesis.
Sampurno S; Bijenhof A; Cheasley D; Xu H; Robine S; Hilton D; Alexander WS; Pereira L; Mantamadiotis T; Malaterre J; Ramsay RG
Cell Death Dis; 2013 Apr; 4(4):e605. PubMed ID: 23618903
[TBL] [Abstract][Full Text] [Related]
17. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H
PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699
[TBL] [Abstract][Full Text] [Related]
18. Kaiso overexpression promotes intestinal inflammation and potentiates intestinal tumorigenesis in Apc(Min/+) mice.
Pierre CC; Longo J; Mavor M; Milosavljevic SB; Chaudhary R; Gilbreath E; Yates C; Daniel JM
Biochim Biophys Acta; 2015 Sep; 1852(9):1846-55. PubMed ID: 26073433
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of CYP26A1 in adenomatous polyposis coli-deficient vertebrates via a WNT-dependent mechanism: implications for intestinal cell differentiation and colon tumor development.
Shelton DN; Sandoval IT; Eisinger A; Chidester S; Ratnayake A; Ireland CM; Jones DA
Cancer Res; 2006 Aug; 66(15):7571-7. PubMed ID: 16885356
[TBL] [Abstract][Full Text] [Related]
20. KLF4 Suppresses Tumor Formation in Genetic and Pharmacological Mouse Models of Colonic Tumorigenesis.
Ghaleb AM; Elkarim EA; Bialkowska AB; Yang VW
Mol Cancer Res; 2016 Apr; 14(4):385-96. PubMed ID: 26839262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
